Your session is about to expire
← Back to Search
Alianza Latina Program for Dementia
Phase 1
Recruiting
Led By Jaime Perales Puchalt, PhD, MPH
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with mild cognitive impairment or dementia
Be older than 18 years old
Must not have
Not having a caregiver 18 years old or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the 15 months of the whole intervention period
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a new way to provide care for Latinos with dementia and their caregivers.
Who is the study for?
This trial is for Latinos aged 65+ living in the community with mild cognitive impairment or dementia, who have a caregiver and access to a cell phone with flat-fee texting. It's not for those without Latino identity, no diagnosis of cognitive issues, no caregiver, or lacking appropriate cell phone access.
What is being tested?
The study tests 'Alianza Latina,' where primary care practitioners are trained to better detect and manage dementia among Latinos. They refer patients to Health Navigators who offer care management and support services.
What are the potential side effects?
Since this trial focuses on training and support services rather than medication, traditional side effects aren't expected. However, participants may experience emotional or psychological impacts from discussing sensitive health information.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with mild cognitive impairment or dementia.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have a caregiver who is 18 or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during the 15 months of the whole intervention period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the 15 months of the whole intervention period
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Importance of Navigators to providers
Overall participant satisfaction with the Navigator side of the intervention
Overall participant satisfaction with the clinic side of the intervention
+12 moreSecondary study objectives
Caregivers' burden
Caregivers' depression
Caregivers' quality of life
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Alianza LatinaExperimental Treatment1 Intervention
The main components of Alianza Latina are 1) providing primary care providers with education, training and tools for timely dementia diagnosis and optimal treatment and 2) providing Latino dementia patients with enhanced chronic care through bilingual Health Navigators.
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
510 Previous Clinical Trials
176,783 Total Patients Enrolled
11 Trials studying Dementia
3,899 Patients Enrolled for Dementia
National Institute on Minority Health and Health Disparities (NIMHD)NIH
434 Previous Clinical Trials
1,378,733 Total Patients Enrolled
1 Trials studying Dementia
139 Patients Enrolled for Dementia
Jaime Perales Puchalt, PhD, MPHPrincipal InvestigatorKUMC
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a caregiver who is at least 18 years old.I have been diagnosed with mild cognitive impairment or dementia.I do not have a caregiver who is 18 or older.
Research Study Groups:
This trial has the following groups:- Group 1: Alianza Latina
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger